This inventor holds 1 USPTO granted patent. Top assignees: Institute for Antibodies Co., Ltd., National Institute of Infectious Diseases, Osaka Prefecture University. Active years: 2013.
Company Filing History:
1 out of 3 
1 out of 37 
1 out of 89 Years Active: 2013
Title: Tomoko Kohda: Innovator in Botulinum Toxin Neutralization
Introduction
Tomoko Kohda is a prominent inventor based in Sakai, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of compositions for neutralizing botulinum toxin type-A. Her innovative work addresses critical health issues related to botulism diseases.
Latest Patents
Tomoko Kohda holds a patent for a composition aimed at neutralizing botulinum toxin type-A and human anti-botulinum toxin type-A antibodies. This patent provides a means that is effective for treating and preventing botulism diseases. Specifically, it includes a plurality of human anti-botulinum toxin type-A antibodies that have different epitopes from one another. The composition comprises a combination of two or more of these antibodies, which exhibit high neutralizing activity.
Career Highlights
Throughout her career, Tomoko has worked with esteemed organizations such as the Institute for Antibodies Co., Ltd. and the National Institute of Infectious Diseases. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Tomoko has collaborated with notable colleagues, including Shunji Kozaki and Gene Kurosawa. These partnerships have further enriched her research and innovation in the field.
Conclusion
Tomoko Kohda's contributions to the neutralization of botulinum toxin type-A highlight her role as a leading inventor in biotechnology. Her innovative approaches and collaborations continue to impact the field positively.